Drug Profile
Neublastin
Alternative Names: Artemin; ARTN; BG-00010; EnovinLatest Information Update: 24 Oct 2021
Price :
$50
*
At a glance
- Originator NsGene
- Developer Biogen; NsGene
- Class Nerve growth factors; Proteins
- Mechanism of Action Neuron stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Neuropathic pain; Radiculopathy; Sciatica
Most Recent Events
- 07 Aug 2015 Discontinued - Phase-I for Sciatica in Australia (SC)
- 27 Jul 2015 Discontinued - Phase-I for Neuropathic pain in Denmark (IV)
- 27 Jul 2015 Discontinued - Phase-I for Radiculopathy in Netherlands (IV)